Cite

HARVARD Citation

    Uronis, H. et al. (2013). A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas. Oncologist. pp. 271-272. [Online]. 
  
Back to record